Latest filing published 20 May 2020 for Harpoon Therapeutics, Inc., €2,956.
Filing timeline
BuySaleInsider track record
Natalie Sacks: trading record in brief
Filings by Natalie Sacks span 2 companies, the busiest being Harpoon Therapeutics, Inc. and Chinook Therapeutics, Inc. We count 48 filings; the first trade dates from 12 September 2016 and the latest from 18 May 2020.
No open-market purchase appears, only 24 sales worth €1.2M. Besides market trades, the filings include 4 share grants and 20 option exercises. Since January 2020: no purchases and 14 sales on the market.
Most recently, on 20 May 2020, the filings show an option exercise worth €2,956 in Harpoon Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Natalie Sacks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,522 shares@ US$2.120.2% of flowCommon StockSEC:0001209191-20-031019:0
- 1,522 shares@ US$14.771.6% of flowCommon StockSEC:0001209191-20-031019:1
- 5,826 shares@ US$2.120.9% of flowCommon StockSEC:0001209191-20-027143:0
- 5,826 shares@ US$12.074.9% of flowCommon StockSEC:0001209191-20-027143:1
- 500 shares@ US$2.120.1% of flowCommon StockSEC:0001209191-20-024947:0
- 500 shares@ US$12.000.4% of flowCommon StockSEC:0001209191-20-024947:1
- 1,021 shares@ US$2.120.2% of flowCommon StockSEC:0001209191-20-024947:2
- 1,021 shares@ US$12.080.9% of flowCommon StockSEC:0001209191-20-024947:3
- 4,556 shares@ US$2.120.7% of flowCommon StockSEC:0001209191-20-024489:0
- 4,556 shares@ US$12.063.8% of flowCommon StockSEC:0001209191-20-024489:1
- 700 shares@ US$2.120.1% of flowCommon StockSEC:0001209191-20-023954:0
- 700 shares@ US$12.000.6% of flowCommon StockSEC:0001209191-20-023954:1
- 570 shares@ US$2.120.1% of flowCommon StockSEC:0001209191-20-023954:2
- 570 shares@ US$12.000.5% of flowCommon StockSEC:0001209191-20-023954:3
- 1 shares@ US$2.120.0% of flowCommon StockSEC:0001209191-20-020052:0
- 1 shares@ US$12.000.0% of flowCommon StockSEC:0001209191-20-020052:1
- 1,520 shares@ US$2.120.2% of flowCommon StockSEC:0001209191-20-020052:2
- 1,520 shares@ US$12.001.2% of flowCommon StockSEC:0001209191-20-020052:3
- 5,826 shares@ US$2.120.8% of flowCommon StockSEC:0001209191-20-015855:0
- 5,826 shares@ US$14.685.9% of flowCommon StockSEC:0001209191-20-015855:1
- 1,521 shares@ US$2.120.2% of flowCommon StockSEC:0001209191-20-011190:0
- 1,521 shares@ US$15.001.6% of flowCommon StockSEC:0001209191-20-011190:1
- 5,826 shares@ US$2.120.8% of flowCommon StockSEC:0001209191-20-006706:0
- 5,826 shares@ US$13.905.5% of flowCommon StockSEC:0001209191-20-006706:1
- 1,521 shares@ US$2.120.2% of flowCommon StockSEC:0001209191-20-004374:0
25 of 48 declarations
